Skip to content

Survey of costs and QOL related to side effects for patients undergoing outpatient chemotherapy

Survey of costs and QOL related to side effects for patients undergoing outpatient chemotherapy - Survey of costs and QOL related to side effects

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000027171
Enrollment
100
Registered
2017-04-27
Start date
2013-12-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

None listed

Sponsors

Gifu Municipal Hospital Department of Pharmacy
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Breast cancer patients who received their first course of intravenous chemotherapy at Gifu Municipal Hospital.

Exclusion criteria

Exclusion criteria: The patients received hormone therapy, only oral anti-cancer drug treatment or radiation therapy.

Design outcomes

Primary

MeasureTime frame
QOL score Before chemotherapy, before 2nd and 3rd course.

Countries

Japan

Contacts

Public ContactKazuhide Tanaka

Gifu Municipal Hospital Department of Pharmacy

k-tanaka@gmhosp.gifu.gifu.jp+81-58-251-1101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026